Literature DB >> 20299618

Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes.

Bryan C Bergman1, Leigh Perreault, Devon M Hunerdosse, Mary C Koehler, Ali M Samek, Robert H Eckel.   

Abstract

Intramuscular triglyceride (IMTG) has received considerable attention as a potential mechanism promoting insulin resistance. Endurance-trained athletes have high amounts of IMTG but are insulin sensitive, suggesting IMTG content alone does not change insulin action. Recent data suggest increased muscle lipid synthesis protects against fat-induced insulin resistance. We hypothesized that rates of IMTG synthesis at rest would be increased in athletes compared with controls. Eleven sedentary men and 11 endurance-trained male cyclists participated in this study. An intravenous glucose tolerance test was performed to assess insulin action. After 3 days of dietary control and an overnight fast, [13C16]palmitate was infused at 0.0174 micromol.kg(-1).min(-1) for 4 h, followed by a muscle biopsy to measure isotope incorporation into IMTG and diacylglycerol. Compared with controls, athletes were twice as insulin sensitive (P=0.004) and had a significantly greater resting IMTG concentration (athletes: 20.4+/-1.6 microg IMTG/mg dry wt, controls: 14.5+/-1.8 microg IMTG/mg dry wt, P=0.04) and IMTG fractional synthesis rate (athletes: 1.56+/-0.37%/h, controls: 0.61+/-0.15%/h, P=0.03). Stearoyl-CoA desaturase 1 mRNA expression (P=0.02) and protein content (P=0.03) were also significantly greater in athletes. Diacylglycerol, but not IMTG, saturation was significantly less in athletes compared with controls (P=0.002). These data indicate endurance-trained athletes have increased synthesis rates of skeletal muscle IMTG and decreased saturation of skeletal muscle diacylglycerol. Increased synthesis rates are not due to recovery from exercise and are likely adaptations to chronic endurance exercise training.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299618      PMCID: PMC2867538          DOI: 10.1152/japplphysiol.00684.2009

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  56 in total

1.  Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects.

Authors:  Joseph A Houmard; Charles J Tanner; Chunli Yu; Paul G Cunningham; Walter J Pories; Kenneth G MacDonald; Gerald I Shulman
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

Review 2.  Minimal model: perspective from 2005.

Authors:  Richard N Bergman
Journal:  Horm Res       Date:  2006-01-20

Review 3.  Lipotoxicity: the obese and endurance-trained paradox.

Authors:  A P Russell
Journal:  Int J Obes Relat Metab Disord       Date:  2004-12

4.  Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans.

Authors:  Matthew W Hulver; Jason R Berggren; Michael J Carper; Makoto Miyazaki; James M Ntambi; Eric P Hoffman; John P Thyfault; Robert Stevens; G Lynis Dohm; Joseph A Houmard; Deborah M Muoio
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

5.  Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding.

Authors:  X Qu; J P Seale; R Donnelly
Journal:  J Endocrinol       Date:  1999-08       Impact factor: 4.286

6.  Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.

Authors:  S K Pinnamaneni; R J Southgate; M A Febbraio; M J Watt
Journal:  Diabetologia       Date:  2006-10-11       Impact factor: 10.122

7.  Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.

Authors:  Guenter Haemmerle; Achim Lass; Robert Zimmermann; Gregor Gorkiewicz; Carola Meyer; Jan Rozman; Gerhard Heldmaier; Robert Maier; Christian Theussl; Sandra Eder; Dagmar Kratky; Erwin F Wagner; Martin Klingenspor; Gerald Hoefler; Rudolf Zechner
Journal:  Science       Date:  2006-05-05       Impact factor: 47.728

8.  Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage.

Authors:  J Michael O'Donnell; Manuela Zampino; Nathaniel M Alpert; Matthew J Fasano; David L Geenen; E Douglas Lewandowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-10-18       Impact factor: 4.310

9.  Evaluation of exercise and training on muscle lipid metabolism.

Authors:  B C Bergman; G E Butterfield; E E Wolfel; G A Casazza; G D Lopaschuk; G A Brooks
Journal:  Am J Physiol       Date:  1999-01

10.  Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.

Authors:  Clinton R Bruce; A Brianne Thrush; Valerie A Mertz; Veronic Bezaire; Adrian Chabowski; George J F Heigenhauser; David J Dyck
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-02-07       Impact factor: 4.310

View more
  45 in total

Review 1.  Insights into Stearoyl-CoA Desaturase-1 Regulation of Systemic Metabolism.

Authors:  Ahmed M ALJohani; Deeba N Syed; James M Ntambi
Journal:  Trends Endocrinol Metab       Date:  2017-10-28       Impact factor: 12.015

2.  Acute high-fat feeding does not prevent the improvement in glucose tolerance after resistance exercise in lean individuals.

Authors:  Christopher S Shaw; Natalie M Cooper; Oliver Shaw; Paulo Salomao; Anton J M Wagenmakers
Journal:  Eur J Appl Physiol       Date:  2011-03-05       Impact factor: 3.078

Review 3.  Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.

Authors:  Bettina Mittendorfer
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-11       Impact factor: 4.294

4.  Measurement of precursor enrichment for calculating intramuscular triglyceride fractional synthetic rate.

Authors:  Xiao-Jun Zhang; Noe A Rodriguez; Lijian Wang; Demidmaa Tuvdendorj; Zhanpin Wu; Alai Tan; David N Herndon; Robert R Wolfe
Journal:  J Lipid Res       Date:  2011-09-20       Impact factor: 5.922

5.  Lipid droplet remodelling and reduced muscle ceramides following sprint interval and moderate-intensity continuous exercise training in obese males.

Authors:  S O Shepherd; M Cocks; P J Meikle; N A Mellett; A M Ranasinghe; T A Barker; A J M Wagenmakers; C S Shaw
Journal:  Int J Obes (Lond)       Date:  2017-07-24       Impact factor: 5.095

6.  Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Lisa S Chow; Shuzhen Li; Lynn E Eberly; Elizabeth R Seaquist; John H Eckfeldt; Ron C Hoogeveen; David J Couper; Lyn M Steffen; James S Pankow
Journal:  Metabolism       Date:  2012-07-21       Impact factor: 8.694

7.  Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats.

Authors:  Vernon W Dolinsky; Kelvin E Jones; Robinder S Sidhu; Mark Haykowsky; Michael P Czubryt; Tessa Gordon; Jason R B Dyck
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

8.  Training status diverges muscle diacylglycerol accumulation during free fatty acid elevation.

Authors:  Lisa S Chow; Douglas G Mashek; Erin Austin; Lynn E Eberly; Xuan-Mai Persson; Mara T Mashek; Elizabeth R Seaquist; Michael D Jensen
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-20       Impact factor: 4.310

9.  Biomarkers of Ectopic Fat Deposition: The Next Frontier in Serum Lipidomics.

Authors:  Leigh Perreault; Anne P Starling; Deborah Glueck; Joseph T Brozinick; Phil Sanders; Parker Siddall; Ming Shang Kuo; Dana Dabelea; Bryan C Bergman
Journal:  J Clin Endocrinol Metab       Date:  2015-11-17       Impact factor: 5.958

Review 10.  Muscle Lipid Droplets: Cellular Signaling to Exercise Physiology and Beyond.

Authors:  Jacob T Seibert; Charles P Najt; Timothy D Heden; Douglas G Mashek; Lisa S Chow
Journal:  Trends Endocrinol Metab       Date:  2020-09-08       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.